1 rd THE 3 ISRAELI NEUROENDOCRINE TUMORS (INET) CONGRESS 22.09.2016-24.09.2016 Crown Plaza Hotel, The Dead Sea PROGRAM Thursday, 22.09.2016 15:00-15:30 Registration 15:30-15:50 Opening Remarks 15:50-16:50 Update in Genetic Analysis of NETs Chair: Prof. Tamar Peretz & Dr. Ofer Purim 15:50-16:10 Any Role for Molecular Analysis in NETs - Where are we now? Prof. Ido Wolf, Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel 16:10-16:30 Epigenetics of NETs. Dr. Asher Salmon, General Director Office, Hadassah Hebrew 16:30-16:50 Methylation Patterns in Cancer - the unrecognized role of transcriptional enhancers. Prof. Asaf Hellman, Developmental Biology and Cancer Research, The Institute for Medical Research Israel-Canada (IMRIC), The Hebrew University-Hadassah Medical School, Jerusalem, Israel. 16:50-17:30 Plenary Lecture: "Genetic Challenges in MEN Syndromes - From MEN1 to MEN4 and Beyond" Chair: Dr. Simona Glasberg Speaker: Prof. Ashley Grossman, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, UK Supported by an educational grant from Israel Cancer Association 17:30-17:50 Coffee Break 1
2 17:50-18:50 Carcinoid Heart Disease (CHD) Chair: Dr. Orit Twito & Prof. Dan Gilon 17:50-18:10 The Pathophysiology of CHD. Dr. Simona Glasberg, NET Unit, Hadassah University Medical Center, Jerusalem, Israel 18:10-18:40 Update in the Approach to CHD - Valve Replacement in Patients with Carcinoid Heart Disease - Choosing the Right Valve at the Right Time. Dr. Amit Korach, Department of Cardio-thoracic surgery, Hadassah 18:40-19:00 Discussion 19:30 Dinner 21:00 Get Together Event Friday, 23.09.2016 8:30-9:30 Update in Thymic and Lung NETs Chair: Prof. Pier Luigi Filosso & Prof. David Gross 8:30-8:50 Update in the Histopathology of Bronchial & Thymic NETs. Dr. Gratiana Hermann, Department of Pathology, Asaf Harofe Medical Center, Israel 8:50-9:10 Therapeutic Approach to Lung and Thymic NETs - lessons from histopathological classification. Prof. Pier Luigi Filosso, Department of Thoracic Surgery, University of Torino, Italy 9:10-9:30 Update in The Surgical Approach in Bronchial & Thymic NETs. Prof. Alon Ben-Nun, Department of Thoracic Surgery, Sheba Medical Center, Israel 9:30-10:30 New Technologies for the Improvement of NET Patient's Care Chair: Prof. Arie Blashar & Prof. Tzila Zwas 9:30-9:50 MRI Advances in NETs. Dr. Naama Lev-Cohain, Department of Medical Imaging, Hadassah 9:50-10:10 Messages From Post-therapy 177 Lu-DOTATATE Images in NETs. Dr. Alexandre Chicheportiche & Dr. Nanette Freedman, Department of Nuclear Medicine, Hadassah University Medical Center, Jerusalem, Israel and Institute of Nuclear Medicine, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel 10:10-10:30 Uses and Misuses of Genomic Technologies in Monogenic Cancer Syndromes. Prof. Lina Basel, The Raphael Recanati Genetics Institute, Rabin 2
3 Medical Center, Beilinson campus and Schneider Children's Medical Center of Israel Petach-Tikva, Israel 10:30-10:50 Coffee Break 10:50-11:20 Plenary Lecture: Immunotherapy in Cancer and in NETs Chair: Dr. Asher Salmon Speaker: Prof. Michal Lotem, Sharett Institute of Oncology, Hadassah Hebrew University Hospital, Jerusalem, Israel Supported by an educational grant from Pfizer Israel 11:20-12:50 Update on Grade 3 NETs Chair: Dr. Amichay Meirovitz & Dr. Esther Osher 11:20-11:40 Update in Low G3 NETs Therapeutic Approach. Prof. Marianne E. Pavel, NET unit, Hepatology and Gastroenterology, Charité Hospital, Berlin, Germany 11:40-12:00 Update in High G3 NETs Therapeutic Approach. Dr. Ravit Geva, Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel 12:00-12:40 Preliminary Experience with PRRT in G3 NETs. Dr. Amichay Meirovitz, Sharett Institute of Oncology, Hadassah Supported by an educational grant from Novartis Oncology 12:40-14:00 Lunch 14:00-15:30 Round Table - Difficult Case Presentations Speakers: Dr. Esther Osher, Institute of Endocrinology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Dr. Orit Twito, Endocrinology Unit, Meir Medical Center, Kfar-Saba, Israel; Dr. Ophra Maimon, Sharett Institute of Oncology, Hadassah Panel: Prof. Ashley Grossman, Prof. Marianne Pavel, Prof. Pier Luigi Filosso, Prof. David J. Gross, Dr. Simona Glasberg, Prof. Ido Wolf, Dr. Amichay Meirovitz, Dr. Asher Salmon. 19:00 Dinner 21:00 Get Together Event 3
4 Saturday, 24.09.2016 07:00-09:00 Breakfast 11:00-12:00 Lecture - TBA 13:00-15:00 Lunch 16:00 Check out (Saturday evening for religious participants) Organizing committee Chairman: Prof. D.J.Gross, Neuroendocrine Tumor Unit, Hadassah Hebrew ; gross@vms.huji.ac.il Secretary: Dr. A. Salmon, Dr. A. Meirovitz, Sharett Institute of Oncology, Hadassah Hebrew ; ASalmon@hadassah.org.il; AmichayM@hadassah.org.il Scientific committee: Dr. S. Glasberg, Neuroendocrine Tumor Unit, Hadassah Hebrew ; simonag@hadassah.org.il ; Prof. I. Wolf, Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel idow@tlvmc.gov.il 4
5 Sponsors: Platinum Sponsor: Novartis Oncology Gold Sponsors: Medison Pharma Pfizer Israel Silver Sonsors: Sanofi Oncotest Teva Educational Grants: Israel Endocrine Society Israel Cancer Association 5